Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helicobacter

Showing results (531-540 of 2,296) with videos related to

Pageof 230
Sort By:
Helicobacter|June 29, 2024
Helicobacter pylori Infection Does Not Protect Against Allergic Diseases: Evidence From a Pediatric Cohort From Northern Sardinia, ItalyMaria Pina Dore, Gianfranco Meloni, Ica Bassu, et al.
Helicobacter|June 20, 2024
Global Primary Antibiotic Resistance Rate of Helicobacter pylori in Recent 10 years: A Systematic Review and Meta-AnalysisYanhui Yu, Jing Xue, Fangbing Lin, et al.
Helicobacter|April 29, 2024
Prevalence of Helicobacter pylori infection among Slovenian children and adolescents: A prospective cohort studyAnja Šterbenc, Uroš Godnov, Polona Maver Vodičar, et al.
Helicobacter|April 29, 2024
14-day tailored PCR-guided triple therapy versus 14-day non-Bismuth concomitant quadruple therapy for Helicobacter pylori eradication: A multicenter, open-label randomized noninferiority controlled trialAurelien Amiot, Jérémy Hacoon, Frederic Heluwaert, et al.
Helicobacter|June 10, 2024
Fourteen-Day Tegoprazan-Amoxicillin Dual Therapy as the First-Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical TrialQingzhou Kong, Iqtida Ahmed Mirza, Xiaoqian Zhang, et al.
Helicobacter|May 17, 2024
Antibiotic susceptibility pattern of Helicobacter pylori against eight antibiotics: A study from North IndiaSafiya Arfi, Prateek Sharma, Mithun Kumar, et al.
Helicobacter|April 17, 2024
Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB targetJing Liu, Jia Jia, Ting Shi, et al.
Helicobacter|April 21, 2024
The role of microbiota in gastric cancer: A comprehensive reviewChangzhen Lei, Yitian Xu, Shaopeng Zhang, et al.
Helicobacter|February 5, 2026
Efficacy and Safety of Keverprazan-Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled TrialShanshan Wei, Zhihao Huang, Huizhen Xiong, et al.
Helicobacter|December 9, 2025
Eradication Rates of Empiric Helicobacter pylori Treatment Regimens by Race/Ethnicity in a Predominantly Immigrant U.S. PopulationMin J Kim, Isiah Gonzalez, Nia M Choi, et al.
Pageof 230

Showing results (531-540 of 2,296) with videos related to

Sort By:
Pageof 230
Helicobacter|June 29, 2024
Helicobacter pylori Infection Does Not Protect Against Allergic Diseases: Evidence From a Pediatric Cohort From Northern Sardinia, ItalyMaria Pina Dore, Gianfranco Meloni, Ica Bassu, et al.
Helicobacter|June 20, 2024
Global Primary Antibiotic Resistance Rate of Helicobacter pylori in Recent 10 years: A Systematic Review and Meta-AnalysisYanhui Yu, Jing Xue, Fangbing Lin, et al.
Helicobacter|April 29, 2024
Prevalence of Helicobacter pylori infection among Slovenian children and adolescents: A prospective cohort studyAnja Šterbenc, Uroš Godnov, Polona Maver Vodičar, et al.
Helicobacter|April 29, 2024
14-day tailored PCR-guided triple therapy versus 14-day non-Bismuth concomitant quadruple therapy for Helicobacter pylori eradication: A multicenter, open-label randomized noninferiority controlled trialAurelien Amiot, Jérémy Hacoon, Frederic Heluwaert, et al.
Helicobacter|June 10, 2024
Fourteen-Day Tegoprazan-Amoxicillin Dual Therapy as the First-Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical TrialQingzhou Kong, Iqtida Ahmed Mirza, Xiaoqian Zhang, et al.
Helicobacter|May 17, 2024
Antibiotic susceptibility pattern of Helicobacter pylori against eight antibiotics: A study from North IndiaSafiya Arfi, Prateek Sharma, Mithun Kumar, et al.
Helicobacter|April 17, 2024
Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB targetJing Liu, Jia Jia, Ting Shi, et al.
Helicobacter|April 21, 2024
The role of microbiota in gastric cancer: A comprehensive reviewChangzhen Lei, Yitian Xu, Shaopeng Zhang, et al.
Helicobacter|February 5, 2026
Efficacy and Safety of Keverprazan-Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled TrialShanshan Wei, Zhihao Huang, Huizhen Xiong, et al.
Helicobacter|December 9, 2025
Eradication Rates of Empiric Helicobacter pylori Treatment Regimens by Race/Ethnicity in a Predominantly Immigrant U.S. PopulationMin J Kim, Isiah Gonzalez, Nia M Choi, et al.
Pageof 230